Agency Forms Undergoing Paperwork Reduction Act Review, 16214-16215 [2021-06288]
Download as PDF
<![CDATA[
16214
Federal Register / Vol. 86, No. 57 / Friday, March 26, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Individuals and Households; Busi- Small discussion groups ..................
nesses and Organizations; and
State, Local, or Tribal Government.
Request for customer comment
cards/complaint forms/post-conference or training surveys.
Focus groups of customers, potential customers, delivery partners,
or other stakeholders.
Qualitative customer satisfaction
surveys or interviews.
Usability testing/in-person observation testing.
Total ...........................................
...........................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–06290 Filed 3–25–21; 8:45 am]
BILLING CODE 4163–70–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–21AT]
khammond on DSKJM1Z7X2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Evaluation of
Venous Thromboembolism Prevention
Practices in U.S. Hospitals to the Office
of Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on November
19, 2020 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
VerDate Sep<11>2014
17:14 Mar 25, 2021
Jkt 253001
Number of
responses per
respondent
Number of
respondents
Type of collection
1
90/60
450
1,500
1
15/60
375
2,000
1
2
4,000
3,000
1
30/60
1,500
1,500
1
30/60
750
........................
........................
........................
7,075
Proposed Project
Evaluation of Venous
Thromboembolism Prevention Practices
in U.S. Hospitals—New—National
Center on Birth Defects and
Developmental Disabilities (NCBDDD),
Frm 00035
Fmt 4703
Total burden
(in hours)
300
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
PO 00000
Hours per
response
Sfmt 4703
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The National Center on Birth Defects
and Disabilities (NCBDDD) is submitting
a New Information Collection Request
for one-year approval. Venous
thromboembolism (VTE) is an important
and growing public health problem.
Over half of VTE events are associated
with recent hospitalization and most
occur after discharge. Hospitalassociated VTE is often preventable but
VTE prevention strategies are not
applied uniformly or systematically
across U.S. hospitals. The framework for
VTE prevention in hospitalized patients
includes a hospital VTE prevention
policy, an interdisciplinary VTE team, a
VTE prevention protocol, monitoring of
processes and outcomes, and VTE
prevention education for providers and
patients. A VTE prevention protocol
includes VTE risk assessment, bleeding
risk assessment, and clinical decision
support for appropriate VTE
prophylaxis. Increase in VTE risk
assessment rates have been associated
with improvements in VTE prophylaxis.
An implementation gap exists
between evidence-based guidelines for
VTE prophylaxis in hospitalized adult
patients and implementation of those
guidelines in real-world hospital
settings. However, data on VTE
prevention practices in U.S. hospitals is
lacking. To address this gap, CDC, in
collaboration with The Joint
Commission, developed a survey on
hospital VTE prevention practices. The
survey will be implemented by The
Joint Commission as an electronic onetime data collection in a nationally
representative sample of U.S. adult
general medical and surgical hospitals.
The target respondent will be the
E:\FR\FM\26MRN1.SGM
26MRN1
16215
Federal Register / Vol. 86, No. 57 / Friday, March 26, 2021 / Notices
hospital Director of Patient Safety and
Quality or similar position. The survey
will be voluntary. No individual-level
data will be collected. CDC will not
receive any individual or hospital
identifiable information.
The information collected will
improve understanding of hospital VTE
prevention practices to guide efforts and
inform interventions to reduce the
burden of hospital-associated VTE.
Information on the capacity of hospitals
to collect data on VTE risk assessment
will be helpful in determining the
feasibility of VTE risk assessment as a
VTE prevention performance measure.
The data collected can also serve as a
baseline for evaluation of future
hospital-associated VTE prevention
initiatives. The estimated annual burden
is 384 hours, based on a pilot of the
electronic survey at 9 hospitals. There is
no cost to respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
The Director of Patient Safety and Quality, the
Chairperson of the Patient Safety Committee,
other quality improvement professional.
Evaluation of Venous Thromboembolism Prevention Practices in
U.S. Hospitals Questionnaire.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–06288 Filed 3–25–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–0740]
Agency Forms Undergoing Paperwork
Reduction Act Review
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Medical
Monitoring Project (MMP) to the Office
of Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on
September 8, 2020 to obtain comments
from the public and affected agencies.
CDC received no comments related to
the previous notice. This notice serves
to allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
VerDate Sep<11>2014
17:14 Mar 25, 2021
Jkt 253001
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Medical Monitoring Project (MMP)—
(OMB Control No. 0920–0740, Exp. 6/
30/2021)—Revision—National Center
for HIV/AIDS, Viral Hepatitis, STD, and
TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC), Division of HIV/AIDS
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
384
1
Average
burden
per response
(in hours)
1
Prevention (DHAP) requests a Revision
of the currently approved Information
Collection Request: ‘‘Medical
Monitoring Project’’ expiring June 30,
2021. This data collection addresses the
need for national estimates of access to,
and utilization of, HIV-related medical
care and services, the quality of HIVrelated ambulatory care, and HIVrelated behaviors and clinical outcomes.
For the proposed project, the same
data collection methods will be used as
for the currently approved project. Data
would be collected from a probability
sample of HIV-diagnosed adults in the
U.S. who consent to an interview and
abstraction of their medical records. As
for the currently approved project, deidentified information would also be
extracted from HIV case surveillance
records for a dataset, referred to as the
minimum dataset, which is used to
assess non-response bias, for quality
control, to improve the ability of MMP
to monitor ongoing care and treatment
of HIV-infected persons, and to make
inferences from the MMP sample to
HIV-diagnosed persons nationally. No
other Federal agency collects such
nationally representative populationbased information from HIV-diagnosed
adults. The data are expected to have
significant implications for policy,
program development, and resource
allocation at the state/local and national
levels.
The changes proposed in this request
update the data collection system to
meet prevailing information needs and
enhance the value of MMP data, while
remaining within the scope of the
currently approved project purpose. The
result is a 10% reduction in burden, or
a reduction of 647 total burden hours
annually. The reduction in burden was
a result of revisions to the interview
questionnaire that were made to
improve coherence, boost the efficiency
E:\FR\FM\26MRN1.SGM
26MRN1
]]>Agencies
[Federal Register Volume 86, Number 57 (Friday, March 26, 2021)]
[Notices]
[Pages 16214-16215]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-06288]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-21-21AT]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Evaluation of Venous Thromboembolism
Prevention Practices in U.S. Hospitals to the Office of Management and
Budget (OMB) for review and approval. CDC previously published a
``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on November 19, 2020 to obtain comments from
the public and affected agencies. CDC did not receive comments related
to the previous notice. This notice serves to allow an additional 30
days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Evaluation of Venous Thromboembolism Prevention Practices in U.S.
Hospitals--New--National Center on Birth Defects and Developmental
Disabilities (NCBDDD), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
The National Center on Birth Defects and Disabilities (NCBDDD) is
submitting a New Information Collection Request for one-year approval.
Venous thromboembolism (VTE) is an important and growing public health
problem. Over half of VTE events are associated with recent
hospitalization and most occur after discharge. Hospital-associated VTE
is often preventable but VTE prevention strategies are not applied
uniformly or systematically across U.S. hospitals. The framework for
VTE prevention in hospitalized patients includes a hospital VTE
prevention policy, an interdisciplinary VTE team, a VTE prevention
protocol, monitoring of processes and outcomes, and VTE prevention
education for providers and patients. A VTE prevention protocol
includes VTE risk assessment, bleeding risk assessment, and clinical
decision support for appropriate VTE prophylaxis. Increase in VTE risk
assessment rates have been associated with improvements in VTE
prophylaxis.
An implementation gap exists between evidence-based guidelines for
VTE prophylaxis in hospitalized adult patients and implementation of
those guidelines in real-world hospital settings. However, data on VTE
prevention practices in U.S. hospitals is lacking. To address this gap,
CDC, in collaboration with The Joint Commission, developed a survey on
hospital VTE prevention practices. The survey will be implemented by
The Joint Commission as an electronic one-time data collection in a
nationally representative sample of U.S. adult general medical and
surgical hospitals. The target respondent will be the
[[Page 16215]]
hospital Director of Patient Safety and Quality or similar position.
The survey will be voluntary. No individual-level data will be
collected. CDC will not receive any individual or hospital identifiable
information.
The information collected will improve understanding of hospital
VTE prevention practices to guide efforts and inform interventions to
reduce the burden of hospital-associated VTE. Information on the
capacity of hospitals to collect data on VTE risk assessment will be
helpful in determining the feasibility of VTE risk assessment as a VTE
prevention performance measure. The data collected can also serve as a
baseline for evaluation of future hospital-associated VTE prevention
initiatives. The estimated annual burden is 384 hours, based on a pilot
of the electronic survey at 9 hospitals. There is no cost to
respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
The Director of Patient Safety and Evaluation of Venous 384 1 1
Quality, the Chairperson of the Thromboembolism
Patient Safety Committee, other Prevention Practices in
quality improvement professional. U.S. Hospitals
Questionnaire.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-06288 Filed 3-25-21; 8:45 am]
BILLING CODE 4163-18-P
